Tag: Gleason score

A new paper on PSA screening for prostate cancer (PCa) begins by pointing out that screening reduces PCa deaths; however, PSA followed by immediate biopsy increases cases of low-risk patients who have overly aggressive treatments that leave them with impaired urinary or sexual function—up to 12 years or more![i] The authors propose more refined screening keep reading

The “Story of the Three Bears” has captured the imagination of millions of children since its original version was published in 1837. The tale has evolved over time. In modern versions, the mischief-making invader of the bears’ home has changed from a bad-tempered old woman to Goldilocks, a hungry girl wandering in a forest. Let’s keep reading

What do these three things have in common: Benign prostatic hyperplasia or BPH (non-cancerous prostate enlargement),male pattern baldness and aggressive prostate cancer that is potentially lethal? The first—and most obvious—answer is that they are all risks that men face with aging. The second less obvious answer is... keep reading

Once upon a fairly recent time, radical prostatectomy (RP) was the treatment of choice for prostate cancer (PCa), even for high risk disease. There were two main reasons for this: It was believed that PCa was a multifocal disease scattered throughout the gland, even if too small to be picked up by biopsy. Therefore, aggressively keep reading

Contrary to popular belief, a new study says you’re never too old to get high-risk prostate cancer (PCa). There’s been a recent trend to cut back on PSA screening for men over age 70. It wasn’t that long ago when such organizations as the American Urological Society and the American Society of Clinical Oncology promoted keep reading

The quote, “Aging is not for sissies,” is attributed to actress Bette Davis but no doubt millions of senior citizens can easily get on board with that sentiment. After age 65, chances of disease and accidents begin to increase, including chronic disease (diabetes, heart disease, cancer, stroke are the most common), falling, depression, anxiety, dementia keep reading

In September, 2018 we posted a blog on this promising news of the IsoPSA blood test for prostate cancer (PCa). Then, in October 2019, the FDA granted breakthrough device designation to the test, in order to work closely with the manufacturer to expedite approval. This move sprang from... keep reading

In the 5+ years since we posted the blog below, a new grading system called Gleason grade group has simplified the two-number system, which was confusing for patients. For example, in Gleason 7 prostate cancer (PCa), what’s the difference between... keep reading

In 2014, the International Society of Urological Pathology released a proposed new prostate cancer grading system, called the Grade Groups (GG). Our initial post explains some of the reasoning behind simplifying the traditional Gleason scoring system into a more understandable 5-point aggression scale... keep reading

In one sense, the greatest cure for cancer is to keep it from happening in the first place. Your local drugstore may be the source of inexpensive products that help protect men against prostate cancer such as... keep reading